PetMed Express Inc (PETS)
Official siteHEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ
Market Cap: $19.96M
Last updated: Nov 17, 2026 at 4:10 PM ET
PetMed Express Inc (PETS) Stock Chart
PetMed Express (PETS) has a latest price of $0.90 on Nov 17, 2026, 78.1% below its 52-week high of $4.10. Its price fell 55.0% over the past 12 months. The month-end price fell 94.0% over the 10 years through Oct 2026, a compound annual decline of 24.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $47.54 in Jul 2017 and its lowest $1.19 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PETS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PETS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 49.2%, and over 6 months it fell 59.3%. The month-end price fell 82.7% over the 3 years through Oct 2026, a compound annual decline of 44.3%.
| Period | Change |
|---|---|
| 1 month | -21.8% |
| 3 months | -49.2% |
| 6 months | -59.3% |
| 12 months | -55.0% |
| 12 months, with dividends | -55.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -82.7% | -44.3% |
| 5 years | -95.8% | -47.0% |
| 10 years | -94.0% | -24.5% |
Price by Year
Its best calendar year was 2017, when the price rose 97.2%, and its weakest was 2023, when it fell 57.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.19 | -62.8% |
| 2025 | $3.20 | -33.6% |
| 2024 | $4.82 | -36.2% |
| 2023 | $7.56 | -57.3% |
| 2022 | $17.70 | -29.9% |
| 2021 | $25.26 | -21.2% |
| 2020 | $32.06 | +36.3% |
| 2019 | $23.52 | +1.1% |
| 2018 | $23.26 | -48.9% |
| 2017 | $45.50 | +97.2% |
Trading Range
The price is 31.5% below its 50-day average of $1.31 and 54.6% below its 200-day average of $1.98.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.90 | |
| 52-week high | $4.10 | -78.1% |
| 52-week low | $0.85 | +5.8% |
| 50-day average | $1.31 | -31.5% |
| 200-day average | $1.98 | -54.6% |
Price Risk
Over 3 years, its largest fall from a peak was 88.4%.
| Measure | Value |
|---|---|
| 1-year beta | 0.89 |
| Largest fall, 1 year | -77.0% |
| Largest fall, 3 years | -88.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PETS
What is PETS's 1-year price change?
PetMed Express's price fell 55.0% over the past 12 months. With dividends included, the 12-month total return was -55.0%.
What is PETS's 5-year price change?
PetMed Express's month-end price fell 95.8% over the 5 years through Oct 2026, a compound annual decline of 47.0%. These figures leave out dividends.
What is PETS's 52-week high and low?
PetMed Express's 52-week high is $4.10 and its 52-week low is $0.85. Its latest price of $0.90 on Nov 17, 2026 is 78.1% below the high.
What is PETS's beta?
PetMed Express's 1-year beta against the S&P 500 is 0.89, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 77.0%.
Is the PETS chart free?
Yes. Advanced Charting for PETS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PETS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors